Your browser doesn't support javascript.
loading
Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery.
Nozhat, Zahra; Heydarzadeh, Shabnam; Shahriari-Khalaji, Mina; Wang, Shibo; Iqbal, M Zubair; Kong, Xiangdong.
Afiliação
  • Nozhat Z; Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China. kongxd@zstu.edu.cn.
  • Heydarzadeh S; Cellular and Molecular Endocrine Research Center, Research Institute of Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shahriari-Khalaji M; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai, 201620, China.
  • Wang S; Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China. kongxd@zstu.edu.cn.
  • Iqbal MZ; Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China. kongxd@zstu.edu.cn.
  • Kong X; Institute of Smart Biomedical Materials, School of Materials Science and Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China. kongxd@zstu.edu.cn.
Biomater Sci ; 11(12): 4094-4131, 2023 Jun 13.
Article em En | MEDLINE | ID: mdl-37073998
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Glioblastoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Biomater Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Glioblastoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Biomater Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China